|
000
| 01020nam##2200229za#4500 |
|---|
| 001 | 9.698677 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210625000034 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407|2013||||xxc|||||o f|0| 0 eng|d |
|---|
| 020 | |a978-1-100-22990-4 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-15/2013E-PDF |
|---|
| 110 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 245 | 14|aThe drivers of prescription drug expenditures : |h[electronic resource]|ba methodological report / |c[by the] National Prescription Drug Utilization Information System (NPDUIS). |
|---|
| 260 | |aOttawa - Ontario : |bPatented Medicine Prices Review Board |cDecember 2013. |
|---|
| 300 | |a53p.|breferences, tables |
|---|
| 590 | |a14-01|b2014-01-03 |
|---|
| 690 | 07|aPrescription drugs|2gcpds |
|---|
| 775 | 08|tLes facteurs de coût associés aux dépenses en médicaments d'ordonnance : |w(CaOODSP)9.642674 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s1.37 MB|uhttps://publications.gc.ca/collections/collection_2013/cepmb-pmprb/H82-15-2013-eng.pdf |
|---|